192 related articles for article (PubMed ID: 28182794)
1. Identification of several high-risk HPV inhibitors and drug targets with a novel high-throughput screening assay.
Toots M; Ustav M; Männik A; Mumm K; Tämm K; Tamm T; Ustav E; Ustav M
PLoS Pathog; 2017 Feb; 13(2):e1006168. PubMed ID: 28182794
[TBL] [Abstract][Full Text] [Related]
2. Modular cell-based platform for high throughput identification of compounds that inhibit a viral interferon antagonist of choice.
Vasou A; Paulus C; Narloch J; Gage ZO; Rameix-Welti MA; Eléouët JF; Nevels M; Randall RE; Adamson CS
Antiviral Res; 2018 Feb; 150():79-92. PubMed ID: 29037975
[TBL] [Abstract][Full Text] [Related]
3. A Cell-Based
Walhart T; Isaacson-Wechsler E; Ang KH; Arkin M; Tugizov S; Palefsky JM
SLAS Discov; 2020 Jan; 25(1):79-86. PubMed ID: 31361520
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of a stable luciferase dengue virus for high-throughput screening.
Zou G; Xu HY; Qing M; Wang QY; Shi PY
Antiviral Res; 2011 Jul; 91(1):11-9. PubMed ID: 21575658
[TBL] [Abstract][Full Text] [Related]
5. Development of a simple system for screening anti-hepatitis C virus drugs utilizing mutants capable of vigorous replication.
Yu L; Aoki C; Shimizu Y; Shimizu K; Hou W; Yagyu F; Wen X; Oshima M; Iwamoto A; Gao B; Liu W; Gao GF; Kitamura Y
J Virol Methods; 2010 Nov; 169(2):380-4. PubMed ID: 20713089
[TBL] [Abstract][Full Text] [Related]
6. A high capacity assay for inhibitors of human papillomavirus DNA replication.
Plumpton M; Sharp NA; Liddicoat LH; Remm M; Tucker DO; Hughes FJ; Russell SM; Romanos MA
Biotechnology (N Y); 1995 Nov; 13(11):1210-4. PubMed ID: 9636294
[TBL] [Abstract][Full Text] [Related]
7. Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus.
Yang CC; Tsai MH; Hu HS; Pu SY; Wu RH; Wu SH; Lin HM; Song JS; Chao YS; Yueh A
Antiviral Res; 2013 May; 98(2):228-41. PubMed ID: 23499649
[TBL] [Abstract][Full Text] [Related]
8. A quantitative and high-throughput assay of human papillomavirus DNA replication.
Gagnon D; Fradet-Turcotte A; Archambault J
Methods Mol Biol; 2015; 1249():305-16. PubMed ID: 25348316
[TBL] [Abstract][Full Text] [Related]
9. Development of Basal-Like HaCaT Keratinocytes Containing the Genome of Human Papillomavirus (HPV) Type 11 for Screening of Anti-HPV Effects.
Wang Y; Li X; Song S; Wu J
J Biomol Screen; 2014 Sep; 19(8):1154-63. PubMed ID: 24874507
[TBL] [Abstract][Full Text] [Related]
10. High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease.
Balasubramanian A; Manzano M; Teramoto T; Pilankatta R; Padmanabhan R
Antiviral Res; 2016 Oct; 134():6-16. PubMed ID: 27539384
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening.
Hao W; Herlihy KJ; Zhang NJ; Fuhrman SA; Doan C; Patick AK; Duggal R
Antimicrob Agents Chemother; 2007 Jan; 51(1):95-102. PubMed ID: 17060518
[TBL] [Abstract][Full Text] [Related]
12. A novel drug screening assay for papillomavirus specific antiviral activity.
Clark PR; Roberts ML; Cowsert LM
Antiviral Res; 1998 Feb; 37(2):97-106. PubMed ID: 9588842
[TBL] [Abstract][Full Text] [Related]
13. Novel human papillomavirus type 18 replicon and its application in screening the antiviral effects of cytokines.
Satsuka A; Yoshida S; Kajitani N; Nakamura H; Sakai H
Cancer Sci; 2010 Feb; 101(2):536-42. PubMed ID: 19917059
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus complete life cycle screen for identification of small molecules with pro- or antiviral activity.
Gentzsch J; Hinkelmann B; Kaderali L; Irschik H; Jansen R; Sasse F; Frank R; Pietschmann T
Antiviral Res; 2011 Feb; 89(2):136-48. PubMed ID: 21167208
[TBL] [Abstract][Full Text] [Related]
15. High-throughput screening using dengue virus reporter genomes.
Fischl W; Bartenschlager R
Methods Mol Biol; 2013; 1030():205-19. PubMed ID: 23821271
[TBL] [Abstract][Full Text] [Related]
16. Screening methods for influenza antiviral drug discovery.
Atkins C; Evans CW; White EL; Noah JW
Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452
[TBL] [Abstract][Full Text] [Related]
17. High-Throughput Firefly Luciferase Reporter Assays.
Siebring-van Olst E; van Beusechem VW
Methods Mol Biol; 2018; 1755():19-29. PubMed ID: 29671260
[TBL] [Abstract][Full Text] [Related]
18. A high-throughput assay using dengue-1 virus-like particles for drug discovery.
Qing M; Liu W; Yuan Z; Gu F; Shi PY
Antiviral Res; 2010 May; 86(2):163-71. PubMed ID: 20153777
[TBL] [Abstract][Full Text] [Related]
19. Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign.
Smith TM; Lim SP; Yue K; Busby SA; Arora R; Seh CC; Wright SK; Nutiu R; Niyomrattanakit P; Wan KF; Beer D; Shi PY; Benson TE
J Biomol Screen; 2015 Jan; 20(1):153-63. PubMed ID: 25252731
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of luciferase and GFP-expressing Nipah viruses for rapid quantitative antiviral screening.
Lo MK; Nichol ST; Spiropoulou CF
Antiviral Res; 2014 Jun; 106():53-60. PubMed ID: 24680955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
